ArticleFrontiers in cellular and infection microbiology2025
Free cMSAP flap for the treatment of chronic osteomyelitis with complex soft tissue defects in foot and ankle.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anatomical study of the medial sural artery perforator flap and its application in the reconstruction of infected defects.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic osteomyelitis is very difficult to treat, numerous reconstructive strategies have been described for repairing soft tissue defect combined with chronic osteomyelitis in the foot and ankle. The free chimeric medial sural artery perforator (cMSAP) flap has been recommended for reconstructing the complicated wounds. We conducted a retrospective study on 16 patients who accepted cMSAP flap to reconstruct the soft tissue defect in the setting of chronic osteomyelitis in foot and ankle from January 2021 to December 2023. The effect of surgery and the functional evaluation of the limb were assessed. Results displayed that no chronic osteomyelitis was recurrent, no cases needed bulky flap defatting and the functions of the lower extremity were all improved at the last follow-up. The free cMSAP flap is a good alternative for reconstructing complex soft tissue defects with deep dead space in the setting of chronic osteomyelitis in the foot and ankle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.